Skip to content
Home/Companies/TMT/Eurocept Pharmaceuticals
Eurocept Pharmaceuticals

Eurocept Pharmaceuticals

TMT·Netherlands·Exited 2022
Entry
–
Hold
–
Exit
2022

Who owns Eurocept Pharmaceuticals?

Eurocept Pharmaceuticals was owned by Gimv, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Gimv
Investor
Gimv
Fund attribution unclassified.

Key facts

HQNetherlands
SectorTMT
Websitewww.euroceptinternational.com
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2022

More from Gimv Portfolio

Other portfolio companies in the same fund.

Ablynx
Exited 2013
TMTBelgium
Acceo
Acceo
Active
TMTBelgium
Acertys Group
Exited 2015
TMTBelgium
to
ActoGeniX
Exited 2015
TMTBelgium
to
AgroBiothers
AgroBiothers
Active
TMTBelgium
Almaviva
Almaviva
Exited 2017
TMTBelgium
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

3Bee
3Bee
Active
AgFunderUS
A+ Network
Active
Summit PartnersUS
A10 Networks
A10 Networks
Active
Summit PartnersUS
ABAX
ABAX
Active
InvestcorpNorway
ABC Fitness Solutions
ABC Fitness Solutions
Active
Thoma BravoUS
Acacia Communications
Acacia Communications
Active
Summit PartnersUS
Track Eurocept Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Eurocept Pharmaceuticals?

1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Eurocept Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue